Dr. McGregor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-8714Fax+1 614-293-4281
Summary
- Dr. John McGregor is a neurosurgeon in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center, Nationwide Children's Hospital, and James Cancer Hospital and Solove Research Institute. He received his medical degree from University of Iowa Carver College of Medicine and has been in practice 33 years. He specializes in brain & spinal tumor, neurosurgical spine surgery, skull base, and stereotactic & functional neurosurgery and is experienced in neurosurgical oncology, minimally invasive spine surgery, skull base surgery, stereotactic and functional surgery, and interventional neuroradiology / endovascular neurosurgery.
Education & Training
- The Royal London HospitalSenior Registrar, Neurosurgery, 1990 - 1991
- Ohio State University HospitalResidency, Neurological Surgery, 1985 - 1990
- Ohio State University HospitalInternship, Transitional Year, 1984 - 1985
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1984
- Stanford UniversityBS, Biology, 1976 - 1980
Certifications & Licensure
- OH State Medical License 1985 - 2026
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
- Fellow (FAANS) American Association of Neurological Surgeons
Clinical Trials
- Phase II Study for Patients With Relapsed Primary Central Nervous System Lymphoma Start of enrollment: 2004 Mar 01
- Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury Start of enrollment: 2010 Oct 01
- Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI) Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- 250 citationsBrain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial.David O. Okonkwo, Lori Shutter, Carol Moore, Nancy R. Temkin, Ava M. Puccio
Critical Care Medicine. 2017-11-01 - 121 citationsPhase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.Lee A. Wheeler, Andrea G. Manzanera, Susan Bell, Robert Cavaliere, John M. McGregor
Neuro-Oncology. 2015-11-01 - 108 citationsPhase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaE. Antonio Chiocca, Laura K. Aguilar, Susan Bell, Balveen Kaur, Jayson Hardcastle
Journal of Clinical Oncology. 2011-09-20
Press Mentions
- Public Service Announcement: Ohio State, OhioHealth Conducting New Traumatic Brain Injury Clinical TrialJuly 9th, 2023
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: